Shenyang BrightGrandeur Pharma sell "Urokinase for Injection"

Urokinase for Injection is a thrombolytic that acts directly on the fibrinolytic system. Core indications include acute cardiovascular embolism (acute myocardial infarction, acute massive pulmonary embolism), acute cerebrovascular embolism (acute-phase cerebral embolism), peripheral vascular embolism (fresh arterial or venous thrombosis/embolism in the limbs), and other embolic conditions such as central retinal vascular embolism. Key features include direct action that dissolves clots without requiring metabolic activation, low potential for allergic reaction due to its non-antigenic nature, and time-sensitive use, requiring early administration for acute thromboembolic events.